文献速递免疫规划

亚马逊利什曼原虫抗原经鼻内而非皮下接种可快速扩增抗皮肤利什曼病的保护性免疫

Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis.
PubMed 文献 · Vaccine · 2018-03-26

本研究在BALB/c小鼠模型中比较了亚马逊利什曼原虫前鞭毛体抗原(LaAg)经鼻内与皮下接种后在感染早期的免疫应答差异。结果显示,鼻内接种可预防Th2相关皮肤超敏反应和局部IL-4产生,并伴Th1和Treg相关因子表达增加,而皮下接种主要诱导Th2和TGF-β表达;鼻内接种还能预防皮下接种的疾病加重效应。

要点

  • 鼻内接种LaAg可预防感染早期Th2相关皮肤超敏反应和局部IL-4产生。
  • 鼻内接种伴病灶引流淋巴结Th1和Treg转录因子及细胞因子表达增加。
  • 鼻内接种可预防皮下接种LaAg所致的疾病加重效应。

核心结论

  • 鼻内接种LaAg可能通过预防有害细胞的早期外周扩增,使保护性应答得以充分扩增。

研究设计与样本

  • BALB/c小鼠在足垫感染亚马逊利什曼原虫前,经鼻内或皮下途径接受两剂LaAg。

主要发现

  • 鼻内接种预防了足垫虫体攻击后最初数天内Th2相关皮肤超敏反应和局部IL-4产生。
  • 鼻内接种伴病灶引流淋巴结中Th1(T-bet和IL-12)及Treg(Foxp3和IL-10)转录因子和细胞因子表达增加。
  • 皮下接种LaAg主要导致更高的Th2(GATA3)和TGF-β表达。
  • 鼻内接种后48小时内颈部淋巴结CD4+Foxp3+ Treg细胞数量较未接种小鼠减少,CD4+和CD8+ T细胞短暂增加。
  • 过继转移此类颈部淋巴结细胞可赋予受感染小鼠增强的抗性,模拟鼻内接种的效果。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mucosal but not parenteral vaccination with whole Leishmania amazonensis promastigotes antigens (LaAg) is known to increase host resistance to infection by an as yet unknown immune mechanism. Since early immune responses are critical for infection establishment, in the present study the differential responses elicited by subcutaneous (s.c.) and intranasal (i.n.) vaccination with LaAg were investigated during the initial stages of infection. For that, BALB/c mice were given two LaAg doses by i.n. or s.c. route prior to L. amazonensis infection in the footpad. It was found that mucosal vaccination prevented both T helper (Th) 2-associated cutaneous hypersensitivity and local interleukin (IL)-4 production in the first days after parasite challenge in the footpad. That was accompanied by increased Th1 (T-bet and IL-12) and Treg (Foxp3 and IL-10) transcription factor and cytokine expression in the lesion draining lymph nodes. In contrast, s.c. LaAg predominantly led to higher Th2 (GATA3) and transforming growth factor (TGF)-β expression. Prior i.n. vaccination was able to prevent the disease-exacerbating effect of s.c. vaccination. Although both CD4+ and CD8+ T cells were transiently increased in the cervical lymph nodes (cLN), the numbers of CD4+Foxp3+ regulatory T (Treg) cells decreased within 48 h of i.n. vaccination as compared to non-vaccinated mice. Adoptive transfer of such cLN cells conferred increased resistance to infected mice, mimicking the effect of i.n. vaccination. Altogether, these data indicate that i.n. vaccination with LaAg may prevent early peripheral expansion of detrimental cells normally elicited by active infection or s.c. vaccination, thus allowing full expansion of protective responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pereira Silva Bezerra I, Amaral Abib M, Rossi-Bergmann B, et al. Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis. Vaccine. 2018. PMID: 29599090. doi:10.1016/j.vaccine.2018.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。